Watch SGP. Know when insiders buy.
One email the day a filing lands. Free.
SGP
SpyGlass Pharma, Inc.
26.82
−0.25 −0.92%
USD · close Sep 28
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
59
WATCH · shorts 59
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $897.1MP/E —DIV YIELD —FCF YIELD -3.73%REV TTM —NET INCOME −$39.9MNET CASH —52W 17.56 – 29.68SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$22M | −$19.9M | — | -0.59 | −$14.8M | $1.9M | −$16.8M | Aug 6 |
| Q1 2026 · Mar 31 | — | — | — | −$15.4M | −$13.8M | — | -0.69 | −$13.5M | $676K | −$14.2M | Aug 6 |
| Q2 2025 · Jun 30 | — | — | — | −$9.3M | −$8.7M | — | -3.81 | −$6.3M | $52K | −$6.4M | Aug 6 |
| Q1 2025 · Mar 31 | — | — | — | −$7.4M | −$8.8M | — | -3.96 | −$8.2M | $164K | −$8.4M | Aug 6 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$41.4M | −$39.9M | — | -17.98 | −$32.7M | $789K | −$33.5M | $1.4M | — |
| FY2024 · to Dec 31 | — | — | −$27.1M | −$29.2M | — | -16.31 | −$22M | $2M | −$24M | $0 | — |
Every number comes from SpyGlass Pharma, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.